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Background: This research evaluated the genotoxicity of oil and tincture of H. annuus L. seeds using the micronucleus
assay in bone marrow of mice. The interaction between these preparations and the genotoxic effects of doxorubicin
(DXR) was also analysed (antigenotoxicity test).
Methods: Experimental groups were evaluated at 24-48 h post treatment with N-Nitroso-N-ethylurea (positive
control – NEU), DXR (chemotherapeutic), NaCl (negative control), a sunflower tincture (THALS) and two sources of
sunflower oils (POHALS and FOHALS). Antigenotoxic assays were carried out using the sunflower tincture and oils
separately and in combination with NUE or DXR.
Results: For THALS, analysis of the MNPCEs showed no significant differences between treatment doses (250–
2,000 mg.Kg−1) and NaCl. A significant reduction in MNPCE was observed when THALS (2,000 mg.Kg−1) was
administered in combination with DXR (5 mg.Kg−1). For POHALS or FOHALS, analysis of the MNPCEs also showed
no significant differences between treatment doses (250–2,000 mg.Kg−1) and NaCl. However, the combination
DXR + POHALS (2,000 mg.Kg−1) or DXR + FOHALS (2,000 mg.Kg−1) not contributed to the MNPCEs reduction.
Conclusions: This research suggests absence of genotoxicity of THALS, dose-, time- and sex-independent, and its
combination with DXR can reduce the genotoxic effects of DXR. POHALS and FOHALS also showed absence of
genotoxicity, but their association with DXR showed no antigenotoxic effects.
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The cultivated sunflower (Helianthus annuus L.) is
one of 67 species in the genus Helianthus. It is a di-
cotyledonous plant and a member of the Compositae
(Asteraceae) family, having a typical composite flower
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reproduction in any medium, provided the orthe sunflower variety [2,3]. Nevertheless, the composition
ranges of sunflower dehulled seeds (on a percentage dry
weight basis) is as follows [4]: protein 20.4–40.0%; peptides,
amino acids and other non–protein nitrogen 1–13%; carbo-
hydrates 4–10%; lipids 47–65%; fatty acids (palmitic acid 5–7%,
atearic 2–6%; arachidic acid 0.0–0.3%, oleic acid 15–37%; linoleic
acid 51–73%, and linolenic acid <0.3%); tocopherol 0.07%;
carotenoids 0.01–0.02%; vitamin B1 0.002%; chlorogenic
acid (CGA) 0.5–2.4%; quinic acid (QA) 0.12–0.25%; caffeic acid
(CA) 0.05–0.29%; total minerals 3–4%; potassium 0.67–0.75%;
phosphorus 0.60–0.94%; sulphur 0.26–0.32%; magnesium 0.35–0.41%;
calcium 0.08–0.10%; and sodium 0.02%.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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protect oils against oxidative rancidity. The α form has
the highest biological vitamin E activity, and the γ form
has been reported to have the highest antioxidant ac-
tivity [5]. The sterols found in sunflower oils include
β-sitosterol, stigmasterol, campesterol, δ-5-avenasterol,
and δ-7-stigmasterol [6,7]. Plant sterols are only min-
imally absorbed by humans, and their ingestion appears
to inhibit intestinal cholesterol and bile acid absorption
[8]. Most trace metals in refined, bleached and deodor-
ized sunflower seed oil are removed during processing.
It is particularly important that copper and iron be re-
moved because these metals greatly reduce the oxida-
tive stability of the oil [9]. Other metals, such as lead
and cadmium, are of particular concern due to their
toxicity and their supposed link to coronary heart dis-
ease and hypertension [10].
In drug development, the genotoxicity assays represent
a considerable effort, as most pharmaceutical organiza-
tions evaluate a new therapeutic agent based on in vitro
and in vivo data genotoxic [11]. In this context, tests to
evaluate the genotoxic activity of the plants used by the
population as well as their isolated compounds are ne-
cessary and important for establishing control measures
in widespread use. Furthermore, it is necessary to clarify
the mechanisms and conditions that mediate the pro-
posed biological effect before plants are considered as
therapeutic agents [12]. As far as genotoxicity studies
are concerned, the in vivo micronucleus (MN) assay in
rodent bone marrow plays a crucial role in the test bat-
tery aimed at identifying hazardous mutagens [13]; this
assay is especially suited to assessing genotoxic hazards
because it allows consideration of multiple factors, such
as in vivo metabolism, pharmacokinetics and DNA re-
pair processes, even though these processes vary among
species, among tissues and among genetic endpoints
[14-17]. In addition, understanding the genotoxic effects
induced by phytotherapeutics and foods employing the
mammalian in vivo MN assay has been the goal of sev-
eral researchers groups [18-20].
In order to contribute to the information on the geno-
toxic potential of herbal extracts and food, the present
study evaluated the genotoxic effects of two sources of
oil and tincture of H. annuus L. (sunflower) seeds using
in vivo micronucleus assays in mouse bone marrow. The
effect of the maximum permissible concentration of
H. annuus L. (oils and tincture) on the doxorubicin
(DXR)–induced genotoxic effects in mice bone marrow
was also studied (i.e., antigenotoxicity assay).
Methods
Phytotherapeutics
Tincture and oil of sunflower seeds were purchased com-
mercially and stored according to the manufacturer'srecommendations [tincture of H. annuus L. seeds
(THALS) – Yod Comércio de Produtos Naturais Ltda.,
cat. # 544606, Campinas, SP, Brazil; pharmaceutical
oil of H. annuus L. seeds (POHALS) – Farmácia de
Manipulação Alfenense Ltda., Alfenas, MG, Brazil; food
oil of H. annuus L. seeds (FOHALS) – Agricultural Cargill
S.A., Mairinque, SP, Brazil]. Aliquots (1.5 L) of this tinc-
ture were submitted to solvent removal proceedings by
rotary evaporation (40 rpm) (Rotavapor Model R-215)
coupled in bath heating systems 50–60°C (Bath Heating
model B-491), vacuum pump 500 mmHg (Vacuum Pump
V-700 with Automatic Vacuum Controller V-855), recir-
culator (Recirculator Chiller F-100) and evaporation bottle
(Büchi Labortechnik AG, Switzerland). The final product
was transferred to a reaction bottle 1 L (SCHOTT®
DURAN®) and kept at −20°C for 24 hours in order to
evaluate the freezing of the final product and the ef-
ficacy of the solvent evaporation process [21]. Then, al-
iquots (40 mL) of this final product was transferred
into glass vials penicillin type (50 mL) and lyophilized
(Lyophilizer model Alpha 1–2 LDPlus, Martin Christ
Gefriertrocknungsanlagen GmbH©, Germany) and their
dry mass were measured (Electronic Analytical Balance
AUW-220D, Shimadzu Corp., Kyoto, Japan). The lyophi-
lized final product was prepared in aqueous solvent
(150 mM NaCl in water type 1) at concentrations of
2×, sterilized by filtration (Millipore Corporation, hydro-
philic Durapore® PVDF, 0.22 μm, ∅ 47 mm, cat. # GVWP
047 00), and stored in sterile polypropylene tubes (50 mL)
at −70°C until moment of use.
System – test in vivo
Healthy, heterogeneous, young adult male and female
Swiss albinus (Unib: SW) mice (between 7 and 12 weeks –
pubescent period), with a body weight between 30 g and
40 g (i.e., the variation weight between the animals, for
each sex, should not exceed the ± 20% of medium mass)
were provided by CEMIB (Centro Multidisciplinar para
Investigação Biológica na Área da Ciência em Animais de
Laboratório – UNICAMP; http://www.cemib.unicamp.br/),
and erythrocytes from the bone marrow of these mice were
used in the micronucleus assay [14,17,22]. The animals
were kept in groups of the same sex, in polypropylene
boxes, in an air–conditioned environment to 22°C ± 3°C,
with relative air humidity of 50% ± 20%, and with 12–
hour day–night cycles (i.e., 12 h light and 12 h dark). These
were fed with Purina® Labina commercial rations (Nestlé
Purina Pet Care Company) and water ad libitum, and
acclimated to laboratory conditions for 7 days (a trial
period) before the execution of the experiment. At the
end of the trial period, each animal was weighed and,
according to the weight, received 2 mL/100 g body
weight of the indicated liquid (negative control, positive
control, chemotherapeutic and phytotherapeutic). After
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by CO2 asphyxiation in adapted acrylic chambers [14]. This
research was approved by Committee of Ethics in Research
Involving Animals of UNIFENAS (CEPEAU Protocol No.
04A/2008).
Experimental groups
Groups of animals (consisting of 3 males and 3 females
each) were treated using a single dosing regimen ad-
ministered by gavage (phytotherapeutic and negative
control) or intraperitoneally (chemotherapeutic and posi-
tive control) and two euthanasia times (24 and 48 h), based
on a regulatory recommendation regarding the in vivo mi-
cronucleus assay [14,17]:
▪ Control groups: 150 mM NaCl (negative control),
50 mg.Kg−1 of N-Nitroso-N-ethylurea (positive
control: NEU, Sigma N8509, CAS no. 759-73-9)
and 5 mg.Kg−1 of doxorubicin hydrochloride [20]
(chemotherapeutic: DXR, Eurofarma Laboratórios
Ltda., CAS no. 23214-92-8).
▪ Genotoxicity test (phytotherapeutics): THALS
(250–2,000 mg.Kg−1), POHALS (250–2,000 mg.Kg−1)
and FOHALS (250–2,000 mg.Kg−1). The maximum
tolerated dose (MTD) was defined as (i) the highest
dose that can be administered without inducing
lethality or excessive toxicity during the study
causing moribund euthanasia, or (ii) a dose that
produces some indication of toxicity of the bone
marrow (e.g. a reduction in the proportion of
immature erythrocytes among total erythrocytes in
the bone marrow), or (iii) 2,000 mg.Kg−1 [14,17].
▪ Antigenotoxicity test 1 (phytotherapeutics +
chemotherapeutic) [20]: THALS (2,000 mg.Kg−1) +
DXR (5 mg.Kg−1), FOHALS (2,000 mg.Kg−1) + DXR
(5 mg.Kg−1) and FOHALS (2,000 mg.Kg−1) + DXR
(5 mg.Kg−1).
▪ Antigenotoxicity test 2 (phytotherapeutics + positive
control): THALS (2,000 mg.Kg−1) + NEU (50 mg.Kg−1),
POHALS (2,000 mg.Kg−1) + NEU (50 mg.Kg−1) and
POHALS (2,000 mg.Kg−1) + NEU (50 mg.Kg−1).
Processing the bone marrow and cell analysis
Shortly after euthanasia, the femora were surgically and
aseptically removed, and the animals appropriately dis-
carded. Each femur was sectioned at the proximal end
and the contents of the spinal canal were washed with
1.5 mL of 150 mM NaCl solution and transferred to a
15 mL centrifuge tube [14,17,23]. This material was re-
suspended with a Pasteur pipette to ensure a random
distribution of bone marrow cells. The suspension was
then centrifuged at 1,000 rpm (Centrífuga de Bancada
Microprocessada, Mod. NT 810, Nova Técnica Ind. e
Com. de Equip. para Laboratório Ltda., Piracicaba, SP,Brazil) for 5 minutes. The supernatant was discarded
and the resulting sediment was resuspended in 500 μL
of 150 mM NaCI solution added 4% formaldehyde. The
slides were prepared by smearing (2 slides per animal),
dried at room temperature for 24 h and stained with
Leishman's eosin methylene blue dye [pure dye for
3 min, followed by diluted dye in water type 1 (1:6) for
15 min] to differentiate polychromatic erythrocyte (PCE)
from normochromatic erythrocyte (NCE).
Polychromatic erythrocytes (PCEs) were observed at a
magnification of 1000× using optical microscopy (Nikon
Eclipse E–200), counted (at least 2000 polychromatic
erythrocytes anucleated per animal were scored for the
incidence of micronucleated polychromatic erythrocytes)
with the aid of a digital cell counter (Contador Diferencial
CCS02, Kacil Indústria e Comércio Ltda., PE, Brasil
Contador Diferencial CCS02, Kacil Indústria e Comércio
Ltda., PE, Brazil) and photographed using an 8.1 Mega-
pixel Digital Camera (DC FWL 150). The number of
PCEs and NCEs, the number and frequency of micro-
nucleated polychromatic erythrocytes (MNPCEs) were
reported. In order to evaluate bone-marrow toxicity,
the ratio of PCE to NCE was also observed [14,17]. This
PCE/NCE ratio is an indicator of the acceleration or in-
hibition of erythropoiesis and it has been reported to
vary with scoring time. A continuous decline in the
PCE/NCE ratio may be due to the inhibition of cell div-
ision, the killing of erythroblasts, the removal of dam-
aged cells, or dilution of the existing cell pool with newly
formed cells [20].
Statistical analysis
The data obtained in the micronucleus assay were submit-
ted to one–way analysis of variance (ANOVA), using a fac-
torial scheme of 10 × 2 × 2 (treatment × sex × euthanasia
time), and medium comparison with Tukey's test (α = 0.05)
using SAS® version 9.2 computer software.
Results and discussion
H. annuus L. has been considered an important source
of natural oil for centuries and has been used as a pre-
ventive medicine against diuresis, diarrhoea, and various
inflammatory diseases [24], and has also been used for
the relief of asthmatic symptoms [25], gastric protection
[26,27], its healing properties [28], anti-inflammatory ac-
tion [29] and antimicrobial properties [26,28]. However,
studies aimed at understanding the genotoxic and muta-
genic effects of H. annuus L. were subject of compara-
tively little research [19,30], which drove us to evaluate
the harmful genotoxic and antigenotoxic properties (i.e.,
clastogenicity and/or aneugenicity) of oil and tincture of
H. annuus L. seeds using the MN assay in vivo.
The numbers and frequencies of MNPCEs and the
PCE/NCE ratio in the bone marrow of mice were analyzed
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only tincture (THALS) or oils (POHALS or FOHALS) of
sunflower seeds – genotoxic assays – and for each one of
the groups treated with phytotherapeutics and chemother-
apeutic agent DXR (THALS +DXR, POHALS +DXR or
FOHALS +DXR) – antigenotoxic assays –, as well as con-
trol groups.
For animal groups treated with THALS, analysis of the
MNPCEs showed no significant differences (p < 0.05)
between all the treatment doses (250–2,000 mg.Kg−1)
and negative control (NaCl). These results suggest ab-
sence of genotoxicity of THALS, regardless of the dose
of phytotherapic administration (250–2,000 mg.Kg−1),
the treatment time (24 and 48 h) or the sex of the animal
(male and female). Treatment of mice with 5 mg.Kg−1
DXR significantly induced MNPCE at 24 and 48 h post
treatment and for both sexes, whose MNPCE frequencies
were significantly above (p < 0.05) those observed in the
positive NEU control (50 mg.Kg−1). However, the reduc-
tion in MNPCE (p < 0.05) was observed when THALS
(2,000 mg.Kg−1) is administered in combination with
the chemotherapy agent DXR (5 mg.Kg−1), suggesting
antigenotoxic effects (anticlastogeny and/or antianeugeny).
Therefore, THALS provides a partial protection against the
genotoxic effects induced by DXR in the bone marrow of
mice, regardless of the treatment time (24 and 48 h) or the
sex of the animal, although the genotoxic effect observed
in this treatment combination has is similar (i.e., numbers
and frequencies of MNPCEs) to that observed in NEU-
treated animals. The analysis obtained from the PCE/NCE
ratio showed no significant differences (p < 0.05) between
all doses of THALS (250–2,000 mg.Kg−1), THALS
(2,000 mg.Kg−1) + DXR (5 mg.Kg−1) and negative controls.
These results suggest that there is not systemic toxicity of
THALS and/or DXR under the MN assay conditions,
regardless of the phytotherapeutic doses and times, but
sex-dependent (Table 1).
For animal groups treated with POHALS (Table 2)
or FOHALS (Table 3), analysis of the MNPCEs
showed no significant differences (p < 0.05) between
all the treatment doses (250–2,000 mg.Kg−1) and nega-
tive control (NaCl). These results suggest absence of
genotoxicity for both sources of sunflower oil (pharma-
ceutical and food), regardless of the dose of oil admin-
istration (250–2,000 mg.Kg−1) or treatment time (24
and 48 h), but it was sex-dependent. Treatment of mice
with DXR (5 mg.Kg−1) + POHALS (2,000 mg.Kg−1) or
DXR (5 mg.Kg−1) + FOHALS (2,000 mg.Kg−1) not con-
tribute to the MNPCEs reduction at 24 and 48 h post
treatment and for both sexes, suggesting that both
sources of sunflower oil not decrease the DXR-induced
genotoxic effects and therefore they do not have antige-
notoxic effects (anticlastogeny and/or antianeugeny).
The analysis obtained from the PCE/NCE ratio showedno significant differences (p < 0.05) between all doses of
POHALS (250–2,000 mg.Kg−1) and negative controls,
time-dependent and sex-independent. For FOHALS, the
PCE/NCE ratio showed significant differences (p < 0.05)
only in the highest dose (2,000 mg.Kg−1) tested, time-
independent and sex-dependent. These results suggest
that the systemic toxicity of sunflower oil can be dependent
on its source and its highest dose used. In addition, treat-
ments with DXR (5 mg.Kg−1) + POHALS (2,000 mg.Kg−1)
or DXR (5 mg.Kg−1) + FOHALS (2,000 mg.Kg−1) signifi-
cantly decrease the PCE/NCE ratio in mouse bone mar-
row. These results suggests that the association sunflower
oil and chemotherapeutic agent DXR can potentize the
systemic toxicity, regardless of the sex (only POHALS) and
time (only FOHALS).
For the first time, this research has provided informa-
tion on the genotoxic and antigenotoxic effects of
THALS. However, genotoxic studies of sunflower oil and
oil sunflower ozonized (at a dose limit of 2 g.kg−1.d−1,
based on evidence of toxicity from subchronic studies
via intragastric administration of the product) were pre-
viously carried out using the MN assay in the bone mar-
row of mice using male and female Cenp: NMRI mice
[31]. In this study, the treatment with sunflower oil did
not cause cytotoxic damage to erithrocytes, as reported
in the analyses of the PCE/NCE ratio, which corroborate
with our findings from the pharmaceutical oil and par-
tially with food oil. Likewise, that research proposes the
hypothesis that no clastogenic effect occurs in the bone
marrow of animals treated with the sunflower oil under
experimental conditions [31].
Other studies have investigated the suitability of dif-
ferent vegetable oils for the human diet, reporting re-
ductions in genotoxicity and cancer potentiation by
sesame oil [32] sunflower oil [33], perilla and palm oil
[34], olive, sunflower, peanut, corn, and soy oils [35],
flax seed oil [36], and coconut oil [37], among others.
The possible role of fatty acids, a main component of
vegetable oils, in modulating genotoxicity and carcino-
genicity has also been studied. The genotoxic activity of
vegetable oils [seed oils of sesame, sunflower, wheat
germ, flax, and soy oil, and both first–class extra–virgin
and low–grade (refined) olive oil] consumed by humans
were also tested in a Drosophila somatic mutation and
recombination test (the Drosophila melanogaster SMART
assay) [30]. Flax oil produced the strongest response,
while sesame, wheat germ, and soy oil showed some
genotoxic activity. Sunflower oil and the low–grade olive
oil gave inconclusive results or negative biological diag-
noses, possibly due to lower concentrations of PUFAs,
even as refined products, and extra–virgin olive oil was
clearly not genotoxic. It has been argued that the geno-
toxicity of an oil is most likely due to the fatty acid com-
position of the oil, which after peroxidation can form
Table 1 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h
Treatment Number of PCEs analyzed PCEMNs PCE/(PCE + NCE) NCE (n)
24 h 48 h 24 h 48 h 24 h 48 h 24 h A” 48 h B” 24 h 48 h
(n) A (n) A (%) A’ (%) A’
150 mM NaCl
♀1 2095 2097 7 10 0.33 0.48 1.00 1.00 5 3
♀2 2094 2095 9 10 0.43 0.48 1.00 1.00 6 5
♀3 2087 2089 11 8 0.53 0.38 0.99 0.99 13 11
Σ ♀ Σ 6276 Σ 6281 Σ 27 Σ 28 0.43 ±0.10 0.45 ±0.05 1.00 ±0.00 1.00 ±0.00 Σ 24 Σ 19
♂1 2095 2088 9 13 0.43 0.62 1.00 0.99 5 12
♂2 2055 2088 12 11 0.58 0.53 0.98 0.99 45 12
♂3 2058 2084 7 11 0.34 0.53 0.98 0.99 42 16
Σ ♂ Σ 6208 Σ 6260 Σ 28 Σ 35 0.45 ±0.12 0.56 ±0.06 0.99 ±0.01 0.99 ± 0.00 Σ 92 Σ 40
Σ ♂ and ♀ Σ 12484 Σ 12541 Σ 55 A Σ 63 A 0.44 ±0.08 A’ 0.50 ±0.06 A’ 0.99 ±0.01 A” 1.00 ±0.00 A” Σ 116 Σ 59
N–Nitroso–N–ethylurea – NEU (50 mg.Kg−1)
♀1 2148 2075 38 36 1.77 1.73 0.49 0.65 2252 1125
♀2 1884 2032 32 34 1.70 1.67 0.54 0.81 1616 468
♀3 2002 1948 15 31 0.75 1.59 0.61 0.93 1298 152
Σ ♀ Σ 6034 Σ 6055 Σ 85 Σ 101 1.41 ±0.57 1.67 ±0.07 0.54 ±0.06 0.80 ±0.14 Σ 5166 Σ 1745
♂1 2025 1999 64 31 3.16 1.55 0.41 0.36 2875 3501
♂2 2028 1916 105 40 5.18 2.09 0.51 0.55 1972 1584
♂3 2004 2069 25 38 1.25 1.84 0.67 0.65 996 1131
Σ ♂ Σ 6057 Σ 5984 Σ 194 Σ 109 3.20 ±1.97 1.83 ±0.27 0.53 ±0.13 0.52 ±0.14 Σ 5843 Σ 6216
Σ ♂ and ♀ Σ 12091 Σ 12039 Σ 279 B Σ 210 B 2.30 ±1.66 B’ 1.75 ±0.18 B’ 0.54 ±0.06 B” 0.66 ±0.16 B” Σ 11009 Σ 7961
Doxorubicin hydrochloride – DXR (5 mg.Kg−1)
♀1 2091 2017 49 36 2.34 1.78 0.72 0.96 809 83
♀2 2106 2077 73 63 3.47 3.03 0.98 0.99 44 23
♀3 2056 2092 57 50 2.77 2.39 0.84 0.95 394 108
Σ ♀ Σ 6253 Σ 6186 Σ 179 Σ 149 2.86 ±0.57 2.40 ±0.62 0.85 ±0.13 0.97 ±0.02 Σ 1247 Σ 214
♂1 2067 2086 53 61 2.56 2.92 0.98 0.95 33 114
♂2 2063 2042 56 70 2.71 3.43 0.98 0.97 37 58
♂3 2082 2075 46 50 2.21 2.41 0.99 0.99 18 25
Σ ♂ Σ 6212 Σ 6203 Σ 155 Σ 181 2.50 ±0.26 2.92 ±0.51 0.99 ±0.00 0.97 ±0.02 Σ 88 Σ 197
Σ ♂ and ♀ Σ 12465 Σ 12389 Σ 334C 330C 2.68 ±0.42 C’ 2.66 ±0.43 C’ 0.92 ±0.07 A” 0.97 ±0.01 A” Σ 1335 Σ 411
THALS – Tincture of H. annuus L. seeds (250 mg.Kg−1)
♀1 2097 2192 8 7 0.38 0.32 0.99 0.99 14 12
♀2 2105 2057 7 12 0.33 0.58 0.99 0.99 31 28
♀3 2181 2092 12 12 0.55 0.57 0.99 1.00 19 8
Σ ♀ A A Σ 6383 Σ 6341 Σ 27 Σ 31 0.42 ±0.11 0.49 ±0.15 0.99 ±0.00 0.99 ±0.01 Σ 64 Σ 48
♂1 2041 2070 7 7 0.34 0.34 0.99 1.00 27 10
♂2 2050 2062 9 6 0.44 0.29 0.99 0.99 17 19
♂3 2055 2065 10 12 0.49 0.58 0.99 0.99 12 15
Σ ♂ A A Σ 6146 Σ 6197 Σ 26 Σ 25 0.42 ±0.07 0.40 ±0.16 0.99 ±0.00 0.99 ±0.00 Σ 56 Σ 44
Σ ♂ and ♀ Σ 12529 Σ 12538 Σ 53 A Σ 56 A 0.42 ±0.09 A’ 0.45 ±0.14 A’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 120 Σ 92
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Table 1 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h (Continued)
THALS – Tincture of H. annuus L. seeds (500 mg.Kg−1)
♀1 2086 2146 12 16 0.58 0.75 0.99 0.99 17 22
♀2 2078 2060 12 13 0.58 0.63 0.99 0.99 25 11
♀3 2072 2046 13 11 0.63 0.54 0.99 0.99 30 26
Σ ♀ A A Σ 6236 Σ 6252 Σ 37 Σ 40 0.59 ±0.03 0.64 ±0.10 0.99 ±0.00 0.99 ±0.00 Σ 72 Σ 59
♂1 2071 2075 17 8 0.82 0.39 0.98 0.99 32 13
♂2 2074 2081 12 11 0.58 0.53 0.99 0.99 29 20
♂3 2072 2067 11 10 0.53 0.48 0.99 0.99 22 11
Σ ♂ A A Σ 6217 Σ 6223 Σ 40 Σ 29 0.64 ±0.16 0.47 ±0.07 0.99 ±0.00 0.99 ±0.00 Σ 83 Σ 44
Σ ♂ and ♀ Σ 12453 Σ 12475 Σ 77 A Σ 69 A 0.62 ±0.10 A’ 0.55 ±0.12 A’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 155 Σ 103
THALS – Tincture of H. annuus L. seeds (1,000 mg.Kg−1)
♀1 2083 2165 13 17 0.62 0.79 0.98 0.99 35 17
♀2 2075 2076 12 14 0.58 0.67 0.99 0.99 24 25
♀3 2070 2061 13 14 0.63 0.68 0.98 0.98 49 34
Σ ♀ A A Σ 6228 Σ 6302 Σ 38 Σ 45 0.61 ±0.03 0.71 ±0.06 0.98 ±0.01 0.99 ±0.00 Σ 108 Σ 76
♂1 2079 2084 18 10 0.87 0.48 0.98 0.99 32 31
♂2 2092 2095 13 11 0.62 0.53 0.99 0.99 30 21
♂3 2073 2077 11 8 0.53 0.39 0.98 0.98 32 40
Σ ♂ A A Σ 6244 Σ 6256 Σ 42 Σ 29 0.67 ±0.17 0.46 ±0.07 0.99 ±0.00 0.99 ±0.00 Σ 94 Σ 92
Σ ♂ and ♀ Σ 12472 Σ 12558 Σ 80 A Σ 74 A 0.64 ±0.12 A’ 0.59 ±0.15 A’ 0.98 ±0.00 A” 0.99 ±0.00 A” Σ 202 Σ 168
THALS – Tincture of H. annuus L. seeds (1,500 mg.Kg−1)
♀1 2057 2171 13 17 0.63 0.78 0.98 0.98 42 39
♀2 2061 2063 14 18 0.68 0.87 0.99 0.98 31 36
♀3 2026 2090 10 11 0.49 0.53 0.98 0.99 44 23
Σ ♀ A A Σ 6144 Σ 6324 Σ 37 Σ 46 0.60 ±0.10 0.73 ±0.18 0.98 ±0.00 0.98 ±0.00 Σ 117 Σ 98
♂1 2075 2048 14 12 0.67 0.59 0.98 0.98 45 48
♂2 2063 2076 13 8 0.63 0.39 0.97 0.99 58 24
♂3 2068 2079 17 15 0.82 0.72 0.98 0.99 41 31
Σ ♂ A A Σ 6206 Σ 6203 Σ 44 Σ 35 0.71 ±0.10 0.56 ±0.17 0.98 ±0.00 0.98 ±0.01 Σ 144 Σ 103
Σ ♂ and ♀ Σ 12350 Σ 12527 Σ 81 A Σ 81 A 0.66 ±0.11 A’ 0.65 ±0.18 A’ 0.98 ±0.00 A” 0.98 ±0.00 A” Σ 261 Σ 201
THALS – Tincture of H. annuus L. seeds (2,000 mg.kg−1)
♀1 2055 2061 15 14 0.73 0.68 0.97 0.98 59 39
♀2 2052 2060 17 19 0.83 0.92 0.97 0.98 62 40
♀3 2079 2061 15 15 0.72 0.73 0.98 0.98 35 39
Σ ♀ A A Σ 6186 Σ 6182 Σ 47 Σ 48 0.76 ±0.06 0.78 ±0.13 0.98 ±0.01 0.98 ±0.00 Σ 156 Σ 118
♂1 2145 2071 22 10 1.03 0.48 0.97 0.99 58 29
♂2 2064 2028 8 12 0.39 0.59 0.98 0.97 40 72
♂3 2047 2071 18 15 0.88 0.72 0.97 0.99 56 29
Σ ♂ A A Σ 6256 Σ 6170 Σ 48 Σ 37 0.76 ±0.33 0.60 ±0.12 0.98 ±0.00 0.98 ±0.01 Σ 154 Σ 130
Σ ♂ and ♀ Σ 12442 Σ 12352 Σ 95 A Σ 85 A 0.76 ±0.21 A’ 0.69 ±0.15 A’ 0.98 ±0.01 A” 0.98 ±0.01 A” Σ 310 Σ 248
THALS (2 g.kg−1) + NEU (50 mg.Kg−1)
♀1 2074 2048 27 32 1.30 1.56 0.99 0.85 26 352
♀2 2070 2076 30 27 1.45 1.30 0.99 0.99 30 24
♀3 2079 2083 32 33 1.54 1.58 0.99 0.99 21 17
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Table 1 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h (Continued)
Σ ♀ A A Σ 6223 Σ 6207 Σ 89 Σ 92 1.43 ±0.12 1.48 ±0.16 0.99 ±0.00 0.94 ±0.08 Σ 77 Σ 393
♂1 2077 2076 35 37 1.69 1.78 0.99 0.99 23 24
♂2 2075 2078 36 35 1.73 1.68 0.99 0.99 25 22
♂3 2077 2074 32 37 1.54 1.78 0.99 0.99 23 26
Σ ♂ A A Σ 6229 Σ 6228 Σ 103 Σ 109 1.65 ±0.10 1.75 ±0.06 0.99 ±0.00 0.99 ±0.00 Σ 71 Σ 72
Σ ♂ and ♀ Σ 12452 Σ 12435 Σ 192 B Σ 201 B 1.54 ±0.16 B’ 1.62 ±0.18 B’ 0.99 ±0.00 A” 0.97 ±0.06 A” Σ 148 Σ 465
THALS (2 g.kg−1) + DXR (5 mg.Kg−1)
♀1 2074 2075 36 38 1.74 1.83 0.99 0.99 26 25
♀2 2075 2079 36 29 1.73 1.39 0.99 0.99 25 21
♀3 2074 2082 34 36 1.64 1.73 0.99 0.99 26 18
Σ ♀ A A Σ 6223 Σ 6236 Σ 106 Σ 103 1.70 ±0.06 1.65 ±0.23 0.99 ±0.00 0.99 ±0.00 Σ 77 Σ 64
♂1 2080 2089 34 28 1.63 1.34 0.99 0.99 20 11
♂2 2081 2077 30 34 1.44 1.64 0.99 0.99 19 23
♂3 2090 2082 33 34 1.58 1.63 1.00 0.99 10 18
Σ ♂ A A Σ 6251 Σ 6248 Σ 97 Σ 96 1.55 ±0.10 1.54 ±0.17 0.99 ±0.00 0.99 ±0.00 Σ 49 Σ 52
Σ ♂ and ♀ Σ 12474 Σ 12484 Σ 203 B Σ 199 B 1.63 ±0.11 B’ 1.59 ±0.19 B’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 126 Σ 116
Means with the same letter are not significantly different (p < 0.05).
Shown are data from the controls (NaCl, NEU and DXR), an evaluation of the genotoxicity of THALS, and an evaluation of the antigenotoxicity of THALS
(THALS + NEU and THALS + DXR).
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agreement with evidence from experimental and epi-
demiological studies summarized by Bartsch and col-
laborators (1999) [38]: n–PUFAs are related to the
generation of oxidative DNA damage, a high intake
of n–6 PUFAs is implicated in some types of cancers,
and n–9 MUFAs and n–3 PUFAs may have a role in
cancer prevention. Additionally, it was suggested that
the relative concentrations of short–chain C18:3 n–3
linolenic acid, C18:2 n–6 linoleic acid, and polyphenols
are the major factors responsible for the genotoxicity of
cooking oils in the SMART assay [30]. Despite the ex-
istence of this information, contradictory or inconclu-
sive data were found in the literature. For instance, one
study reported that linoleic acid (C18:2 n–6 PUFA)
suppressed cancer cell proliferation [39], while other
studies indicated an enhancing effect on carcinogenesis
[40,41]. Oleic acid (C18:1, n–9 MUFA), a promoter of
cancer cell proliferation [39], has also been reported
to be an effective anticancer and antigenotoxic agent
[42,43]. Linolenic acid (C18:3 short–chain n–3 PUFA)
had anticancer activity in some studies [39,44], but pro-
moted cancer in other studies [41,45]. Phenolic com-
pounds, another important constituent of vegetable oils,
are present in the unsaponifiable lipid phase. Phenolics
are involved in both extra- and intracellular processes,
inducing cytosolic detoxifying mechanisms, microsomal
enzyme activation, and the scavenging of free radicals
[46,47]. Evidence indicates that polyphenols can inhibitthe genotoxicity of genotoxic agents [48,49] and function
as anticancer agents [50].
The clastogenic and cytotoxic effects from heated
sunflower oil were studied in lymphocytes, hepatocytes
(HepG2) and in human umbilical vein endothelial cells
(HUVEC) [19]. In lymphocytes incubated with water
extract of heated sunflower oil containing 0.075 or
0.15 μM of thiobarbituric acid–reactive substances
(this extract has a high content in polar aldehydes),
the rate of chromosomal breakage was 18.4% and
23.1%, compared to 8.7% and 6.6%, or 8.1% and 9.2%,
respectively in lymphocytes incubated with the same
volume of a water extract from non–heated oil or dis-
tilled water. In HepG2 or HUVEC cells, the cytotoxic
properties of heated sunflower oil were dose dependent,
and the cytotoxicity occurred at concentrations as low
as 0.25 μM. In contrast, the same volume of non–
heated oil or distilled water was non–toxic for these
cells. The results show that a water extract obtained
from heated oil is clastogenic and, in higher doses,
cytotoxic. These data also suggested that a water ex-
tract, obtained from culinary oils submitted to heat
stress, with a high content of aldehydes is clastogenic.
It was speculated that the ingestion of large amounts
of these products may also impact human health, es-
pecially in those diseases secondary to chromosomal
breakage such as certain congenital malformations and
certain types of cancer. This last fact can be corroborated
by previous reports indicating that the administration
Table 2 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h
Treatment Number of PCEs analyzed PCEMNs PCE/(PCE + NCE) NCE (n)
24 h 48 h 24 h 48 h 24 h 48 h 24 h A” 48 h B” 24 h 48 h
(n) A (n) A (%) A’ (%) A’
150 mM NaCl
♀1 2095 2097 7 10 0.33 0.48 1.00 1.00 5 3
♀2 2094 2095 9 10 0.43 0.48 1.00 1.00 6 5
♀3 2087 2089 11 8 0.53 0.38 0.99 0.99 13 11
Σ ♀ Σ 6276 Σ 6281 Σ 27 Σ 28 0.43 ±0.10 0.45 ±0.05 1.00 ±0.00 1.00 ±0.00 Σ 24 Σ 19
♂1 2095 2088 9 13 0.43 0.62 1.00 0.99 5 12
♂2 2055 2088 12 11 0.58 0.53 0.98 0.99 45 12
♂3 2058 2084 7 11 0.34 0.53 0.98 0.99 42 16
Σ ♂ Σ 6208 Σ 6260 Σ 28 Σ 35 0.45 ±0.12 0.56 ±0.06 0.99 ±0.01 0.99 ± 0.00 Σ 92 Σ 40
Σ ♂ and ♀ Σ 12484 Σ 12541 Σ 55 A Σ 63 A 0.44 ±0.08 A’ 0.50 ±0.06 A’ 0.99 ±0.01 A” 1.00 ±0.00 A” Σ 116 Σ 59
N–Nitroso–N–ethylurea – NEU (50 mg.Kg–1)
♀1 2148 2075 38 36 1.77 1.73 0.49 0.65 2252 1125
♀2 1884 2032 32 34 1.70 1.67 0.54 0.81 1616 468
♀3 2002 1948 15 31 0.75 1.59 0.61 0.93 1298 152
Σ ♀ Σ 6034 Σ 6055 Σ 85 Σ 101 1.41 ±0.57 1.67 ±0.07 0.54 ±0.06 0.80 ±0.14 Σ 5166 Σ 1745
♂1 2025 1999 64 31 3.16 1.55 0.41 0.36 2875 3501
♂2 2028 1916 105 40 5.18 2.09 0.51 0.55 1972 1584
♂3 2004 2069 25 38 1.25 1.84 0.67 0.65 996 1131
Σ ♂ Σ 6057 Σ 5984 Σ 194 Σ 109 3.20 ±1.97 1.83 ±0.27 0.53 ±0.13 0.52 ±0.14 Σ 5843 Σ 6216
Σ ♂ and ♀ Σ 12091 Σ 12039 Σ 279 B Σ 210 B 2.30 ±1.66 B’ 1.75 ±0.18 B’ 0.54 ±0.06 C” 0.66 ±0.16 C” Σ 11009 Σ 7961
Doxorubicin hydrochloride – DXR (5 mg.Kg–1)
♀1 2091 2017 49 36 2.34 1.78 0.72 0.96 809 83
♀2 2106 2077 73 63 3.47 3.03 0.98 0.99 44 23
♀3 2056 2092 57 50 2.77 2.39 0.84 0.95 394 108
Σ ♀ Σ 6253 Σ 6186 Σ 179 Σ 149 2.86 ±0.57 2.40 ±0.62 0.85 ±0.13 0.97 ±0.02 Σ 1247 Σ 214
♂1 2067 2086 53 61 2.56 2.92 0.98 0.95 33 114
♂2 2063 2042 56 70 2.71 3.43 0.98 0.97 37 58
♂3 2082 2075 46 50 2.21 2.41 0.99 0.99 18 25
Σ ♂ Σ 6212 Σ 6203 Σ 155 Σ 181 2.50 ±0.26 2.92 ±0.51 0.99 ±0.00 0.97 ±0.02 Σ 88 Σ 197
Σ ♂ and ♀ Σ 12465 Σ 12389 Σ 334 C 330 C 2.68 ±0.42 C’ 2.66 ±0.43 C’ 0.92 ±0.07 A” 0.97 ±0.01 A” Σ 1335 Σ 411
POHALS – Pharmaceutical oil of H. annuus L. seeds (250 mg.Kg–1)
♀1 2081 2092 9 7 0.43 0.33 0.99 1.00 14 10
♀2 2086 2087 5 8 0.24 0.38 0.99 1.00 13 9
♀3 2090 2084 8 8 0.38 0.38 1.00 0.99 7 12
Σ ♀ A A Σ 6257 Σ 6263 Σ 22 Σ 23 0.35 ±0.10 0.37 ±0.03 0.99 ±0.00 1.00 ±0.00 Σ 34 Σ 31
♂1 2082 2083 10 16 0.48 0.77 0.99 0.99 18 11
♂2 2085 2099 7 9 0.34 0.43 0.99 1.00 15 9
♂3 2089 2072 9 15 0.43 0.72 0.99 0.99 11 21
Σ ♂ B A Σ 6256 Σ 6254 Σ 26 Σ 40 0.42 ±0.07 0.64 ±0.18 0.99 ±0.00 0.99 ±0.00 Σ 44 Σ 41
Σ ♂ and ♀ Σ 12513 Σ 12517 Σ 48 A Σ 63 A 0.38 ±0.09 A’ 0.50 ±0.19 A’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 78 Σ 72
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Table 2 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h (Continued)
POHALS – Pharmaceutical oil of H. annuus L. seeds (500 mg.Kg–1)
♀1 2021 2075 6 6 0.30 0.29 1.00 0.99 9 13
♀2 2047 2087 9 11 0.44 0.53 0.99 1.00 11 8
♀3 2034 2089 8 7 0.39 0.34 0.99 0.99 14 11
Σ ♀ A A Σ 6102 Σ 6251 Σ 23 Σ 24 0.38 ±0.07 0.38 ±0.13 0.99 ±0.00 0.99 ±0.00 Σ 34 Σ 32
♂1 2055 2057 10 11 0.49 0.53 0.99 0.99 28 18
♂2 2067 2071 18 15 0.87 0.72 0.99 0.99 11 16
♂3 2076 2082 16 19 0.77 0.91 1.00 0.99 7 12
Σ ♂ B A Σ 6198 Σ 6210 Σ 44 Σ 45 0.71 ±0.20 0.72 ±0.19 0.99 ±0.01 0.99 ±0.00 Σ 46 Σ 46
Σ ♂ and ♀ Σ 12300 Σ 12461 Σ 67 A Σ 69 A 0.54 ±0.24 A’ 0.55 ±0.24 A’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 80 Σ 78
POHALS – Pharmaceutical oil of H. annuus L. seeds (1,000 mg.Kg–1)
♀1 2088 2091 15 11 0.72 0.53 0.99 1.00 12 7
♀2 2084 2086 9 16 0.43 0.77 0.99 0.99 14 14
♀3 2090 2080 11 9 0.53 0.43 1.00 0.99 10 11
Σ ♀ A A Σ 6262 Σ 6257 Σ 35 Σ 36 0.56 ±0.15 0.58 ±0.17 0.99 ±0.00 0.99 ±0.00 Σ 36 Σ 32
♂1 2071 2077 14 23 0.68 1.11 0.99 0.99 18 18
♂2 2087 2093 21 15 1.01 0.72 0.99 0.99 13 11
♂3 2084 2079 17 15 0.82 0.72 0.99 0.99 16 17
Σ ♂ B A Σ 6242 Σ 6249 Σ 52 Σ 53 0.83 ±0.17 0.85 ±0.22 0.99 ±0.00 0.99 ±0.00 Σ 47 Σ 46
Σ ♂ and ♀ Σ 12504 Σ 12506 Σ 87 A Σ 89 A 0.70 ±0.20 A’ 0.71 ±0.23 A’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 83 Σ 78
POHALS – Pharmaceutical oil of H. annuus L. seeds (1,500 mg.Kg–1)
♀1 2091 2088 15 11 0.72 0.53 1.00 0.99 10 12
♀2 2091 2102 10 15 0.48 0.71 1.00 1.00 9 8
♀3 2084 2076 12 12 0.58 0.58 0.99 0.99 19 14
Σ ♀ A A Σ 6266 Σ 6266 Σ 37 Σ 38 0.59 ±0.12 0.61 ±0.10 0.99 ±0.00 0.99 ±0.00 Σ 38 Σ 34
♂1 2079 2084 21 20 1.01 0.96 0.99 0.99 21 16
♂2 2083 2067 18 17 0.86 0.82 0.99 0.99 19 21
♂3 2091 2085 17 21 0.81 1.01 0.99 0.99 18 15
Σ ♂ B A Σ 6253 Σ 6236 Σ 56 Σ 58 0.90 ±0.10 0.93 ±0.10 0.99 ±0.00 0.99 ±0.00 Σ 58 Σ 52
Σ ♂ and ♀ Σ 12519 Σ 12502 Σ 93 A Σ 96 A 0.74 ±0.19 A’ 0.77 ±0.20 A’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 96 Σ 86
POHALS – Pharmaceutical oil of H. annuus L. seeds (2,000 mg.kg–1)
♀1 2084 2091 18 17 0.86 0.81 0.99 1.00 17 9
♀2 2089 2087 16 18 0.77 0.86 0.99 0.99 15 13
♀3 2091 2085 9 13 0.43 0.62 0.99 0.99 11 15
Σ ♀ A A Σ 6264 Σ 6263 Σ 43 Σ 48 0.69 ±0.23 0.77 ±0.13 0.99 ±0.00 0.99 ±0.00 Σ 43 Σ 37
♂1 2071 2074 24 25 1.16 1.21 0.98 0.98 36 32
♂2 2085 2086 18 19 0.86 0.91 0.98 0.99 33 28
♂3 2048 2078 15 18 0.73 0.87 0.99 0.99 27 30
Σ ♂ B A Σ 6204 Σ 6238 Σ 57 Σ 62 0.92 ±0.22 0.99 ±0.18 0.98 ±0.00 0.99 ±0.00 Σ 96 Σ 90
Σ ♂ and ♀ Σ 12468 Σ 12501 Σ 100 A Σ 110 A 0.80 ±0.24 A’ 0.88 ±0.19 A’ 0.99 ±0.00 A” 0.99 ±0.00 A” Σ 139 Σ 127
POHALS (2 g.kg–1) + NEU (50 mg.Kg–1)
♀1 2040 2054 67 51 3.28 2.48 0.73 0.68 760 946
♀2 2042 2068 61 61 2.99 2.95 0.73 0.65 758 1132
♀3 2039 2007 54 64 2.65 3.19 0.70 0.69 861 893
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Table 2 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h (Continued)
Σ ♀ A A Σ 6121 Σ 6129 Σ 182 Σ 176 2.97 ±0.32 2.87 ±0.36 0.72 ±0.01 0.67 ±0.02 Σ 2379 Σ 2971
♂1 2038 2014 46 52 2.26 2.58 0.64 0.69 1162 886
♂2 2011 2072 54 59 2.69 2.85 0.67 0.80 989 528
♂3 2008 2053 49 49 2.44 2.39 0.69 0.76 892 647
Σ ♂ B A Σ 6057 Σ 6139 Σ 149 Σ 160 2.46 ±0.21 2.61 ±0.23 0.67 ±0.03 0.75 ±0.05 Σ 3043 Σ 2061
Σ ♂ and ♀ Σ 12178 Σ 12268 Σ 331 C Σ 336 C 2.72 ±0.37 C’ 2.74 ±0.31 C’ 0.69 ±0.04 B” 0.71 ±0.06 B” Σ 5422 Σ 5032
POHALS (2 g.kg–1) + DXR (5 mg.Kg–1)
♀1 2034 2166 76 52 3.74 2.40 0.64 0.83 1166 434
♀2 2069 2015 51 49 2.46 2.43 0.69 0.69 931 885
♀3 2017 2066 52 59 2.58 2.86 0.70 0.69 883 934
Σ ♀ A A Σ 6120 Σ 6247 Σ 179 Σ 160 2.93 ±0.70 2.56 ±0.25 0.67 ±0.03 0.74 ±0.08 Σ 2980 Σ 2253
♂1 2057 2017 53 55 2.58 2.73 0.66 0.78 1043 583
♂2 2056 2037 73 51 3.55 2.50 0.59 0.75 1444 663
♂3 2081 2021 47 49 2.26 2.42 0.74 0.78 719 579
Σ ♂ B A Σ 6194 Σ 6075 Σ 173 Σ 155 2.80 ±0.67 2.55 ±0.16 0.66 ±0.08 0.77 ±0.01 Σ 3206 Σ 1825
Σ ♂ and ♀ Σ 12314 Σ 12322 Σ 352 C Σ 315 C 2.86 ±0.62 C’ 2.56 ±0.19 C’ 0.67 ±0.05 B” 0.75 ±0.05 B” Σ 6186 Σ 4078
Means with the same letter are not significantly different (p < 0.05).
Shown are data from the controls (NaCl, NEU and DXR), an evaluation of the genotoxicity of POHALS, and an evaluation of the antigenotoxicity of POHALS
(POHALS + NEU and POHALS + DXR).
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genic [51].
Doxorubicin (DXR) is an important anthracyclines an-
ticancer agent. It is a valuable component of various
chemotherapeutic regimens for breast carcinoma and
small-cell lung carcinoma. In metastatic thyroid carcin-
oma, DXR is most likely the best available agent [20].
However, DXR has been reported to induce micronuclei,
chromatid and chromosome aberrations, and DNA
single- and double-strand breaks in vitro and in vivo
[52-56]. The genotoxicity of anticancer drugs is of special
interest because of the risk of inducing secondary malig-
nancies. Therefore, it is essential to screen for newer
pharmacological agents that can protect the normal cells
against DXR–induced cumulative (geno) toxicity. Many
plants that have been widely used in traditional medi-
cine are less toxic than pharmaceutical agents and have
recently attracted the attention of researchers around
the world. Plants contain many compounds, and it is
likely that these can provide better protective effects
than a single molecule [57]. The presence of many mol-
ecules in plants may be advantageous, as some of them
may counteract the toxicity of others, and as a result,
the net effect may be beneficial for therapeutic pur-
poses. For example, the effect of various concentrations
(200, 250, 300, 350, and 400 mg/kg body weight) of Aegle
marmelos on the doxorubicin (DXR)–induced genotoxic
effects in mice bone marrow was studied [20]. Treatment
of mice with different concentrations of DXR (5, 10, or15 mg.kg−1 body weight) resulted in a dose–dependent
elevation in the frequency of micronucleated polychro-
matic and normochromatic erythrocytes in mouse bone
marrow, and it was accompanied by a DXR dose–
dependent decline in the PCE/NCE ratio. The treat-
ment of mice with Aegle marmelos, orally once daily
for 5 consecutive days before DXR treatment, signifi-
cantly reduced the frequency of DXR–induced micro-
nuclei and significant increased the PCE/NCE ratio at
all scoring times. This observed chemoprotective effect
may be due to the sum total of interaction between dif-
ferent ingredients of this complex mixture. The degree
of protection may depend on the interaction of compo-
nents individually or collectively with the genotoxic
agent. The plausible mechanisms of action of Aegle
marmelos in protecting against DXR–induced genomic
insult were scavenging of O2
•– and •OH and other free
radicals, increase in antioxidant status, restoration of
topoisomerase II activity, and inhibition of the formation
of DXR–iron complex [20]. Another study was under-
taken to evaluate the genotoxic potential of Copaifera
langsdorffii Desf. leaf hydroalcoholic extract and its influ-
ence on the genotoxicity induced by chemotherapeutic
agent DXR using the Swiss mouse peripheral blood mi-
cronucleus test. The results of this study demonstrated
that C. langsdorffii Desf. was not itself genotoxic and that
in animals treated with C. langsdorffii Desf. and DXR,
the number of micronuclei was significantly decreased
compared to animals receiving DXR alone. The putative
Table 3 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h
Treatment Number of PCEs analyzed PCEMNs PCE/(PCE + NCE) NCE (n)
24 h 48 h 24 h 48 h 24 h 48 h 24 h A” 48 h A” 24 h 48 h
(n) A (n) A (%) A’ (%) A’
150 mM NaCl
♀1 2095 2097 7 10 0.33 0.48 1.00 1.00 5 3
♀2 2094 2095 9 10 0.43 0.48 1.00 1.00 6 5
♀3 2087 2089 11 8 0.53 0.38 0.99 0.99 13 11
Σ ♀ Σ 6276 Σ 6281 Σ 27 Σ 28 0.43 ±0.10 0.45 ±0.05 1.00 ±0.00 1.00 ±0.00 Σ 24 Σ 19
♂1 2095 2088 9 13 0.43 0.62 1.00 0.99 5 12
♂2 2055 2088 12 11 0.58 0.53 0.98 0.99 45 12
♂3 2058 2084 7 11 0.34 0.53 0.98 0.99 42 16
Σ ♂ Σ 6208 Σ 6260 Σ 28 Σ 35 0.45 ±0.12 0.56 ±0.06 0.99 ±0.01 0.99 ± 0.00 Σ 92 Σ 40
Σ ♂ and ♀ Σ 12484 Σ 12541 Σ 55 A Σ 63 A 0.44 ±0.08 A’ 0.50 ±0.06 A’ 0.99 ±0.01 A” 1.00 ±0.00 A” Σ 116 Σ 59
N–Nitroso–N–ethylurea – NEU (50 mg.Kg−1)
♀1 2148 2075 38 36 1.77 1.73 0.49 0.65 2252 1125
♀2 1884 2032 32 34 1.70 1.67 0.54 0.81 1616 468
♀3 2002 1948 15 31 0.75 1.59 0.61 0.93 1298 152
Σ ♀ Σ 6034 Σ 6055 Σ 85 Σ 101 1.41 ±0.57 1.67 ±0.07 0.54 ±0.06 0.80 ±0.14 Σ 5166 Σ 1745
♂1 2025 1999 64 31 3.16 1.55 0.41 0.36 2875 3501
♂2 2028 1916 105 40 5.18 2.09 0.51 0.55 1972 1584
♂3 2004 2069 25 38 1.25 1.84 0.67 0.65 996 1131
Σ ♂ Σ 6057 Σ 5984 Σ 194 Σ 109 3.20 ±1.97 1.83 ±0.27 0.53 ±0.13 0.52 ±0.14 Σ 5843 Σ 6216
Σ ♂ and ♀ Σ 12091 Σ 12039 Σ 279 B Σ 210 B 2.30 ±1.66 B’ 1.75 ±0.18 B’ 0.54 ±0.06 D” 0.66 ±0.16 D” Σ 11009 Σ 7961
Doxorubicin hydrochloride – DXR (5 mg.Kg−1)
♀1 2091 2017 49 36 2.34 1.78 0.72 0.96 809 83
♀2 2106 2077 73 63 3.47 3.03 0.98 0.99 44 23
♀3 2056 2092 57 50 2.77 2.39 0.84 0.95 394 108
Σ ♀ Σ 6253 Σ 6186 Σ 179 Σ 149 2.86 ±0.57 2.40 ±0.62 0.85 ±0.13 0.97 ±0.02 Σ 1247 Σ 214
♂1 2067 2086 53 61 2.56 2.92 0.98 0.95 33 114
♂2 2063 2042 56 70 2.71 3.43 0.98 0.97 37 58
♂3 2082 2075 46 50 2.21 2.41 0.99 0.99 18 25
Σ ♂ Σ 6212 Σ 6203 Σ 155 Σ 181 2.50 ±0.26 2.92 ±0.51 0.99 ±0.00 0.97 ±0.02 Σ 88 Σ 197
Σ ♂ and ♀ Σ 12465 Σ 12389 Σ 334C 330C 2.68 ±0.42 C’ 2.66 ±0.43 C’ 0.92 ±0.07 AB” 0.97 ±0.01 AB” Σ 1335 Σ 411
FOHALS – Food oil of H. annuus L. seeds (250 mg.Kg−1)
♀1 2137 2019 11 9 0.51 0.45 0.99 0.99 24 14
♀2 2142 2073 7 14 0.33 0.68 1.00 1.00 8 5
♀3 2146 2016 9 7 0.42 0.35 0.99 1.00 12 6
Σ ♀ A A Σ 6425 Σ 6108 Σ 27 Σ 30 0.42 ±0.09 0.49 ±0.17 0.99 ±0.00 1.00 ±0.00 Σ 44 Σ 25
♂1 2061 2079 6 10 0.29 0.48 0.95 0.94 98 140
♂2 2093 2093 8 7 0.38 0.33 0.99 0.99 31 20
♂3 2050 2041 8 6 0.39 0.29 0.99 0.97 30 59
Σ ♂ B B Σ 6204 Σ 6213 Σ 22 Σ 23 0.35 ±0.03 0.37 ±0.10 0.98 ±0.02 0.97 ±0.03 Σ 159 Σ 219
Σ ♂ and ♀ Σ 12629 Σ 12321 Σ 49 A Σ 53 A 0.39 ±0.08 A’ 0.43 ±0.14 A’ 0.98 ±0.02 A” 0.98 ±0.02 A” Σ 203 Σ 244
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Table 3 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h (Continued)
FOHALS – Food oil of H. annuus L. seeds (500 mg.Kg−1)
♀1 2014 2046 10 11 0.50 0.54 0.98 0.99 39 24
♀2 2007 2094 8 8 0.40 0.38 0.95 0.98 106 34
♀3 2010 2035 9 16 0.45 0.79 0.96 0.99 81 11
Σ ♀ A A Σ 6031 Σ 6175 Σ 27 Σ 35 0.45 ±0.05 0.57 ±0.20 0.96 ±0.02 0.99 ±0.01 Σ 226 Σ 69
♂1 2037 2082 10 10 0.49 0.48 0.95 0.94 116 135
♂2 2063 2067 8 16 0.39 0.77 0.96 0.96 78 89
♂3 2053 2078 5 9 0.24 0.43 0.95 0.97 102 63
Σ ♂ B B Σ 6153 Σ 6227 Σ 23 Σ 35 0.37 ±0.12 0.56 ±0.18 0.95 ±0.01 0.96 ±0.02 Σ 296 Σ 287
Σ ♂ and ♀ Σ 12184 Σ 12402 Σ 50 A Σ 70 A 0.41 ±0.09 A’ 0.57 ±0.17 A’ 0.96 ±0.01 AB” 0.97 ±0.02 AB” Σ 522 Σ 356
FOHALS – Food oil of H. annuus L. seeds (1,000 mg.Kg−1)
♀1 2114 2083 11 16 0.52 0.77 0.98 0.98 36 48
♀2 2148 2058 11 13 0.51 0.63 0.96 0.97 84 72
♀3 2097 2090 8 9 0.38 0.43 0.93 0.95 149 106
Σ ♀ A A Σ 6359 Σ 6231 Σ 30 Σ 38 0.47 ±0.08 0.61 ±0.17 0.96 ±0.02 0.97 ±0.01 Σ 269 Σ 226
♂1 2073 2026 9 17 0.43 0.84 0.90 0.96 227 74
♂2 2065 2071 12 13 0.58 0.63 0.99 0.94 20 129
♂3 2003 2084 5 8 0.25 0.38 0.95 0.91 97 207
Σ ♂ B B Σ 6141 Σ 6181 Σ 26 Σ 38 0.42 ±0.17 0.62 ±0.23 0.95 ±0.02 0.94 ±0.03 Σ 344 Σ 410
Σ ♂ and ♀ Σ 12500 Σ 12412 Σ 56 A Σ 76 A 0.45 ±0.12 A’ 0.61 ±0.18 A’ 0.95 ±0.03 AB” 0.95 ±0.02 AB” Σ 613 Σ 636
FOHALS – Food oil of H. annuus L. seeds (1,500 mg.Kg−1)
♀1 2065 2021 6 15 0.29 0.74 0.98 0.90 35 236
♀2 2041 2081 13 10 0.64 0.48 0.93 0.89 159 262
♀3 2068 2072 11 14 0.53 0.68 0.89 0.88 247 294
Σ ♀ A A Σ 6174 Σ 6174 Σ 30 Σ 39 0.49 ±0.18 0.63 ±0.14 0.93 ±0.05 0.89 ±0.01 Σ 441 Σ 792
♂1 2106 2087 10 18 0.47 0.86 0.92 0.96 194 94
♂2 2011 2088 5 11 0.25 0.53 0.91 0.94 189 126
♂3 2039 2128 14 16 0.69 0.75 0.98 0.88 38 277
Σ ♂ B B Σ 6156 Σ 6303 Σ 29 Σ 45 0.47 ±0.22 0.71 ±0.17 0.94 ±0.04 0.93 ±0.04 Σ 421 Σ 497
Σ ♂ and ♀ Σ 12330 Σ 12477 Σ 59 A Σ 84 A 0.48 ±0.18 A’ 0.67 ±0.15 A’ 0.94 ±0.04 AB” 0.91 ±0.03 AB” Σ 862 Σ 1289
FOHALS – Food oil of H. annuus L. seeds (2,000 mg.kg−1)
♀1 2084 2015 11 13 0.53 0.65 0.89 0.86 245 325
♀2 2096 2025 13 11 0.62 0.54 0.91 0.83 216 407
♀3 2076 2002 9 17 0.43 0.85 0.95 0.94 114 126
Σ ♀ A A Σ 6256 Σ 6042 Σ 33 Σ 41 0.53 ±0.09 0.68 ±0.16 0.92 ±0.03 0.88 ±0.06 Σ 575 Σ 858
♂1 2057 2199 16 20 0.78 0.91 0.94 0.97 143 65
♂2 2016 2158 17 12 0.84 0.56 0.95 0.86 110 347
♂3 2106 2133 11 15 0.52 0.70 0.92 0.89 194 261
Σ ♂ B B Σ 6179 Σ 6490 Σ 44 Σ 47 0.71 ±0.17 0.72 ±0.18 0.93 ±0.02 0.91 ±0.06 Σ 447 Σ 673
Σ ♂ and ♀ Σ 12435 Σ 12532 Σ 77 A Σ 88 A 0.62 ±0.16 A’ 0.70 ±0.15 A’ 0.92 ±0.02 B” 0.89 ±0.05 B” Σ 1022 Σ 1531
FOHALS (2 g.kg−1) + NEU (50 mg.Kg−1)
♀1 2020 2062 54 49 2.67 2.38 0.70 0.74 880 738
♀2 2080 2052 44 52 2.12 2.53 0.80 0.68 520 948
♀3 2008 2011 50 54 2.49 2.69 0.69 0.74 892 689
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Table 3 The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female Swiss albinus mice after
testing for 24 h and 48 h (Continued)
Σ ♀ A A Σ 6108 Σ 6125 Σ 148 Σ 155 2.43 ±0.28 2.53 ±0.15 0.73 ±0.06 0.72 ±0.03 Σ 2292 Σ 2375
♂1 2031 2013 50 67 2.46 3.33 0.73 0.75 769 687
♂2 2010 2054 43 67 2.14 3.26 0.65 0.76 1090 646
♂3 2042 2045 56 71 2.74 3.47 0.64 0.71 1158 855
Σ ♂ B B Σ 6083 Σ 6112 Σ 149 Σ 205 2.45 ±0.30 3.35 ±0.11 0.67 ±0.05 0.74 ±0.03 Σ 3017 Σ 2188
Σ ♂ and ♀ Σ 12191 Σ 12237 Σ 297C Σ 360C 2.44 ±0.26 C’ 2.94 ±0.47 C’ 0.70 ±0.06 C” 0.73 ±0.03 C” Σ 5309 Σ 4563
FOHALS (2 g.kg−1) + DXR (5 mg.Kg−1)
♀1 2007 2051 50 54 2.49 2.63 0.77 0.82 593 449
♀2 2010 2033 64 49 3.18 2.41 0.77 0.88 590 267
♀3 2094 2031 51 54 2.44 2.66 0.84 0.85 406 369
Σ ♀ A A Σ 6111 Σ 6115 Σ 165 Σ 157 2.70 ±0.42 2.57 ±0.14 0.79 ±0.04 0.85 ±0.03 Σ 1589 Σ 1085
♂1 2128 2067 67 66 3.15 3.19 0.85 0.67 372 1033
♂2 2015 2053 79 65 3.92 3.17 0.69 0.71 885 847
♂3 2054 2041 66 60 3.21 2.94 0.64 0.66 1146 1059
Σ ♂ B B Σ 6197 Σ 6161 Σ 212 Σ 191 3.43 ±0.43 3.10 ±0.14 0.73 ±0.11 0.68 ±0.03 Σ 2403 Σ 2939
Σ ♂ and ♀ Σ 12308 Σ 12276 Σ 377C Σ 348C 3.07 ±0.55 C’ 2.83 ±0.32 C’ 0.76 ±0.08 C” 0.76 ±0.10 C” Σ 3992 Σ 4024
Means with the same letter are not significantly different (p < 0.05).
Shown are data from the controls (NaCl, NEU and DXR), an evaluation of the genotoxicity of FOHALS, and an evaluation of the antigenotoxicity of FOHALS
(FOHALS + NEU and FOHALS + DXR).
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pounds of C. langsdorffii Desf., including two major flavon-
oid heterosides (quercitrin and afzelin), may explain the
effect of this plant on DXR genotoxicity [18].
Conclusions
In conclusion, this research observed an absence of gen-
otoxicity of a tincture and two oils of sunflower seeds,
regardless of the dose tested and the treatment time
(24–48 h), but sex-independent (sunflower tincture)
or sex-dependent (sunflower oils). Antigenotoxic effects
(anticlastogeny and/or antianeugeny) were observed using
only a dose of the sunflower tincture in association with
the chemotherapy agent DXR. Therefore, the sunflower
tincture can promote a partial protection against the geno-
toxic effects induced by DXR. The sunflower tincture no
showed systemic toxicity and it was dose- and time-
independent and sex-dependent, whereas the systemic
toxicity of sunflower oil can be dependent on its source
and its highest dose used.
Other studies involving the genotoxicity and antigeno-
toxicity of H. annuus L. extracts and oils (seeds, flowers
and leaves) should be conducted [including genotoxicity
assays with Salmonella typhimurium test (Ames test) as
an indicator of potential carcinogenicity to mammals,
gene mutation test in mammalian cells (mouse lymph-
oma assay), cytogenetic and aneuploidy tests in vitro,
micronucleus test in cultured cells in vitro, fluorescent
in situ hybridization (FISH) test for mutagenesis, comettest to detect of DNA damage and repair in individual
cells, and functional genomic and proteomic tests for
mutagenesis (cDNA microarrays and other array ana-
lyses)], to characterize the potential effects and geno-
toxic and antigenotoxic mechanisms and, importantly,
for the establishment of limits for human consumption,
the delineation of potential risks to human health, and
for rational strategies for implementing chemo-preventive
measures.
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